MBA: Healthcare Investment Decision
Analysis Exam Practice Questions And
Correct Answers (Verified Answers)
Question 1: Which of the following is NOT a primary risk factor in
healthcare investment?
A) Policy and regulatory changes
B) Market competition
C) Technological obsolescence
D) The phase of the business cycle in non-healthcare sectors
Correct Answer: D The phase of the business cycle in non-healthcare
sectors
Rationale: While the general economic environment can have an
indirect effect, healthcare is often considered a defensive sector that is
less correlated with the broad economic business cycle. The primary,
direct risks in healthcare investing are specific to the industry: policy
changes (e.g., drug pricing reform, approval pathways), competitive
dynamics, and the risk that a technology or device becomes outdated .
,Question 2: According to the practice exam materials, which of the
following is considered a common risk type in healthcare investment?
A) Investor sentiment risk
B) Currency fluctuation risk
C) Operational risk
D) Commodity price risk
Correct Answer: C Operational risk
Rationale: Operational risk—the risk of loss resulting from inadequate
or failed internal processes, people, and systems—is a fundamental risk
category for any healthcare business, from a biotech startup to a large
hospital system. This is distinct from financial risks like currency or
commodity price fluctuations .
Question 3: What makes "technological risk" particularly significant in
healthcare investments?
A) Technology is easy to replicate.
B) A new innovation can render a current product obsolete and destroy
its market value.
C) Healthcare patents are weak and easily challenged.
D) Regulatory bodies approve all new technologies quickly.
Correct Answer: B A new innovation can render a current product
obsolete and destroy its market value.
Rationale: The healthcare industry is driven by innovation. A significant
risk is that a competitor will develop a new drug, device, or procedure
that is more effective, safer, or less expensive, rendering the current
,investment's technology obsolete and wiping out its projected revenue
streams .
Question 4: A risk-averse investor is looking at the healthcare sector.
Which of the following strategies is most appropriate for them?
A) Concentrating their capital in a single, early-stage biotech firm
B) Investing in a diversified healthcare mutual fund or ETF
C) Using margin to invest in high-growth medical device IPOs
D) Focusing solely on companies with no earnings
Correct Answer: B Investing in a diversified healthcare mutual fund or
ETF
Rationale: Diversification is a key strategy for managing risk. By
investing in a fund that holds a broad portfolio of healthcare stocks
across different sub-sectors (pharma, biotech, devices, services) and
stages of development, an investor reduces the impact of any single
company's failure on their overall portfolio .
Question 5: A pharmaceutical company's main drug is set to lose its
patent protection in two years. This situation primarily exposes an
investor to which type of risk?
A) Technological risk
B) Market competition risk
C) Operational risk
D) Financing risk
Correct Answer: B Market competition risk
, Rationale: The loss of patent exclusivity exposes the drug to
competition from generic manufacturers, who can sell the same
molecule at a significantly lower price. This almost always leads to a
dramatic drop in revenue for the original drug, representing a major
market competition risk .
Section 2: Financial Analysis & Valuation (Q6-12)
Question 6: Which of the following is a key financial analysis indicator
for evaluating a healthcare investment project?
A) The personal brand of the CEO
B) The company's logo and marketing materials
C) The Internal Rate of Return (IRR)
D) The number of news articles written about the company
Correct Answer: C The Internal Rate of Return (IRR)
Rationale: IRR is a core financial metric used to estimate the
profitability of potential investments. It is the discount rate that makes
the net present value (NPV) of all cash flows from a particular project
equal to zero. It is a fundamental tool in capital budgeting and
investment analysis .
Question 7: Which valuation method is most suitable for a mature
healthcare company with stable and positive earnings?
Analysis Exam Practice Questions And
Correct Answers (Verified Answers)
Question 1: Which of the following is NOT a primary risk factor in
healthcare investment?
A) Policy and regulatory changes
B) Market competition
C) Technological obsolescence
D) The phase of the business cycle in non-healthcare sectors
Correct Answer: D The phase of the business cycle in non-healthcare
sectors
Rationale: While the general economic environment can have an
indirect effect, healthcare is often considered a defensive sector that is
less correlated with the broad economic business cycle. The primary,
direct risks in healthcare investing are specific to the industry: policy
changes (e.g., drug pricing reform, approval pathways), competitive
dynamics, and the risk that a technology or device becomes outdated .
,Question 2: According to the practice exam materials, which of the
following is considered a common risk type in healthcare investment?
A) Investor sentiment risk
B) Currency fluctuation risk
C) Operational risk
D) Commodity price risk
Correct Answer: C Operational risk
Rationale: Operational risk—the risk of loss resulting from inadequate
or failed internal processes, people, and systems—is a fundamental risk
category for any healthcare business, from a biotech startup to a large
hospital system. This is distinct from financial risks like currency or
commodity price fluctuations .
Question 3: What makes "technological risk" particularly significant in
healthcare investments?
A) Technology is easy to replicate.
B) A new innovation can render a current product obsolete and destroy
its market value.
C) Healthcare patents are weak and easily challenged.
D) Regulatory bodies approve all new technologies quickly.
Correct Answer: B A new innovation can render a current product
obsolete and destroy its market value.
Rationale: The healthcare industry is driven by innovation. A significant
risk is that a competitor will develop a new drug, device, or procedure
that is more effective, safer, or less expensive, rendering the current
,investment's technology obsolete and wiping out its projected revenue
streams .
Question 4: A risk-averse investor is looking at the healthcare sector.
Which of the following strategies is most appropriate for them?
A) Concentrating their capital in a single, early-stage biotech firm
B) Investing in a diversified healthcare mutual fund or ETF
C) Using margin to invest in high-growth medical device IPOs
D) Focusing solely on companies with no earnings
Correct Answer: B Investing in a diversified healthcare mutual fund or
ETF
Rationale: Diversification is a key strategy for managing risk. By
investing in a fund that holds a broad portfolio of healthcare stocks
across different sub-sectors (pharma, biotech, devices, services) and
stages of development, an investor reduces the impact of any single
company's failure on their overall portfolio .
Question 5: A pharmaceutical company's main drug is set to lose its
patent protection in two years. This situation primarily exposes an
investor to which type of risk?
A) Technological risk
B) Market competition risk
C) Operational risk
D) Financing risk
Correct Answer: B Market competition risk
, Rationale: The loss of patent exclusivity exposes the drug to
competition from generic manufacturers, who can sell the same
molecule at a significantly lower price. This almost always leads to a
dramatic drop in revenue for the original drug, representing a major
market competition risk .
Section 2: Financial Analysis & Valuation (Q6-12)
Question 6: Which of the following is a key financial analysis indicator
for evaluating a healthcare investment project?
A) The personal brand of the CEO
B) The company's logo and marketing materials
C) The Internal Rate of Return (IRR)
D) The number of news articles written about the company
Correct Answer: C The Internal Rate of Return (IRR)
Rationale: IRR is a core financial metric used to estimate the
profitability of potential investments. It is the discount rate that makes
the net present value (NPV) of all cash flows from a particular project
equal to zero. It is a fundamental tool in capital budgeting and
investment analysis .
Question 7: Which valuation method is most suitable for a mature
healthcare company with stable and positive earnings?
